Search

Dr Reddy's Laboratories Ltd-ADR

Gesloten

SectorGezondheidszorg

11.89 1.54

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

11.89

Max

11.95

Belangrijke statistieken

By Trading Economics

Inkomsten

2.1B

4.3B

Verkoop

4.9B

81B

K/W

Sectorgemiddelde

28.5

56.597

EPS

0.06

Dividendrendement

0.7

Winstmarge

5.356

Werknemers

27,527

EBITDA

-5.8B

3B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+36.93% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.70%

2.18%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-463M

10B

Vorige openingsprijs

10.35

Vorige sluitingsprijs

11.89

Nieuwssentiment

By Acuity

50%

50%

126 / 339 Rangschikking in Healthcare

Dr Reddy's Laboratories Ltd-ADR Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 sep 2026, 12:41 UTC

News

Solana is trading higher as investor interest in cryptocurrency strengthens, aided by positive momentum from Ethereum and Pepeto's successful presale raising $10.96 million.

12 sep 2026, 00:06 UTC

Macro News
Macro Event
News

Bitcoin trades higher, nearing $79,000, as the market rebounds from $388 million in liquidations amid inflation concerns and declining crude oil prices.

12 sep 2026, 00:01 UTC

News

Kroger Co reported mixed second-quarter results, with shares lower in after-market trading. EPS guidance for the fiscal year is set between $5.10 and $5.30.

12 sep 2026, 00:01 UTC

Social Media
News

Scholar Rock Holding Corp shares rose in after-market trading following FDA approval of ISEMBYLD for spinal muscular atrophy, with commercial supply set to begin shortly.

12 sep 2026, 00:01 UTC

News

Nasdaq Inc announced a $100 million investment in Payward to develop blockchain-based equities, launching Nasdaq Equity Tokens in 2027. Shares traded higher in after-market hours.

12 sep 2026, 00:01 UTC

News
Social Media

Johnson & Johnson shares rose in after-hours trading amid reports of Apollo Global Management discussing a $20 billion acquisition of its DePuy Synthes unit.

12 sep 2026, 00:01 UTC

Social Media
News

Corning Inc shares fell in after-market trading following a $2 billion common stock offering announcement, raising investor concerns over potential dilution.

11 sep 2026, 23:56 UTC

News

Ionis Pharmaceuticals received FDA approval for ZANVASTRO. Shares are higher in after-market trading, reflecting positive sentiment despite a setback in a partnered trial.

11 sep 2026, 23:41 UTC

News
Social Media

Johnson & Johnson shares higher after news of Apollo Global Management's interest in acquiring its $20 billion orthopedics unit, DePuy Synthes.

11 sep 2026, 23:26 UTC

News

Bentley Systems declared a quarterly dividend of $0.07 per share, scheduled for September 29, 2026, with shares trading higher in after-market hours.

11 sep 2026, 23:16 UTC

News

Carriage Services Inc shares higher in after-hours trading, following a Friday close. Analysts set an average price target of $51.00, indicating potential upside.

11 sep 2026, 23:06 UTC

Macro Event
News

Ethereum is higher in Friday's session, recovering after four days of declines. The asset remains above its 20-day moving average amid rising inflation pressures.

11 sep 2026, 23:06 UTC

Macro Event
News

Ethereum is rising during Friday's session, supported by recent inflation data and fluctuating crude oil prices. The asset remains above its 20-day moving average.

11 sep 2026, 23:01 UTC

Social Media
News

Oracle Corp's after-market shares declined following a $700 million expansion of its restructuring plan, raising total costs to $2.8 billion amid financial pressures.

11 sep 2026, 23:01 UTC

News

Nasdaq Inc. shares rose in after-market trading following a $100 million investment in Payward to develop Nasdaq Equity Tokens, set to launch in 2027.

11 sep 2026, 23:01 UTC

Social Media
News

Corning Inc shares fell in after-market trading following a $2 billion stock offering announcement, raising investor concerns about potential dilution.

11 sep 2026, 22:51 UTC

News
Social Media

Scholar Rock Holding Corp gains after FDA approves ISEMBYLD for spinal muscular atrophy, with a U.S. launch set to begin shortly.

11 sep 2026, 22:01 UTC

News

Estée Lauder Companies secured a legal win against Walmart over counterfeit products, but shares are trading lower in after-market hours amid ongoing retail sector concerns.

11 sep 2026, 21:31 UTC

News

Warner Bros Discovery Inc. shares are higher in after-market hours following reports of Paramount's settlement talks with state attorneys general over its acquisition proposal.

11 sep 2026, 20:51 UTC

News

Ralph Lauren Corp's Board declared a quarterly dividend of $1.00 per share, and shares are trading higher in after-market hours.

11 sep 2026, 20:09 UTC

News

1-800-Flowers.Com Inc shares are lower after reporting Q2 revenue of $293.1 million and a non-GAAP loss of $0.80 per share.

11 sep 2026, 20:09 UTC

News

Century Communities plans to open Grand Oaks of Callaway in Florida on September 26, featuring homes starting from the upper $200s. Shares are gaining.

11 sep 2026, 20:09 UTC

News

Columbia Sportswear appoints Peter Rauch as President of Mountain Hardwear, effective September 28. Shares are higher today, despite pulling back from an earlier session high.

11 sep 2026, 20:09 UTC

News

Clear Secure shares are lower after DA Davidson analyst Wyatt Swanson cut the price target to $45.00 from $55.00 while maintaining a Neutral rating.

11 sep 2026, 20:09 UTC

News

Carvana Co's shares are lower today, continuing a downward trend amid institutional investment activity and persistent inflation pressures indicated by recent CPI data.

11 sep 2026, 20:09 UTC

News

Ultragenyx Pharmaceutical shares are lower as Bronstein, Gewirtz & Grossman, LLC, initiates an investigation following disappointing Phase 3 study results for apazunersen.

11 sep 2026, 20:09 UTC

News
Social Media
Correlated Moves

Snowflake Inc. shares are declining amid insider selling by director Benoit Dageville, who sold 50,000 shares at $335.72 on September 9.

11 sep 2026, 20:09 UTC

News
Social Media

Advanced Micro Devices shares are higher today following positive growth projections for its server and data center businesses, potentially exceeding $65 billion by Q4 2026.

11 sep 2026, 20:09 UTC

News

Intercontinental Exchange sponsors the 9/11 Day of Service initiative. Shares are advancing during Friday's trading, reflecting positive momentum since Thursday's close.

11 sep 2026, 20:09 UTC

News
Social Media

Marvell Technology reports fiscal Q2 revenue of $2.73 billion, exceeding estimates. Shares are higher amid strong demand for AI networking and advanced technologies.

Peer Vergelijking

Prijswijziging

Dr Reddy's Laboratories Ltd-ADR Prognose

Koersdoel

By TipRanks

36.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 16.295 USD  36.93%

Hoogste 16.295 USD

Laagste 16.295 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Dr Reddy's Laboratories Ltd-ADR - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Sentiment

By Acuity

126 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
help-icon Live chat